PROTEXT MOBILITY, INC.

Press Releases ProText Mobility, Inc.

Equities

TXTM

US74371E2046

Market Closed - OTC Markets Other stock markets 01:29:28 11/05/2024 am IST			5-day change	1st Jan Change
0.0008 ^USD	-11.11%		-55.56%	-52.94%

2022	Protext Mobility, Inc and RSAMMDA LLC Provides the Shareholder Update	CI
2021	ProText Mobility, Inc. Provides Updates on Research Conducted At A Licensed Facility	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PROTEXT MOBILITY, INC. (TXTM) ADDRESSES ALLEGED PROMOTIONAL ACTIVITY AND OTC MARKETS CE DESIGNATION	14/22/14	AQ
PROTEXT MOBILITY, INC. (TXTM) AND RSAMMDA LLC (DELAWARE) PROVIDES SHAREHOLDER UPDATE	02/22/02	EQ
PROTEXT MOBILITY, INC. (TXTM) AND RSAMMDA LLC (DELAWARE) PROVIDES SHAREHOLDER UPDATE	02/22/02	AQ
RSAMMD ACQUISITIONS LLC AND PROTEXT MOBILITY, INC. (TXTM) PROVIDE SHAREHOLDERS UPDATE AND NEAR TERM ROAD MAP	01/22/01	AQ
ProText Mobility : Quarterly Report - Protext Q3 2021 - Amended	03/21/03	PU
ProText Mobility : Quarterly Report	22/21/22	PU
ProText Mobility : Notification of Late Filing	16/21/16	PU
PROTEXT MOBILITY ANNOUCNES SIGNING OF LETTER OF INTENT TO ACQUIRE PREMIER VODKA BRAND	29/21/29	AQ
Republic of South Africa Medical Marijuana Dispensaries (RSAMMD) Announces Successful Testing Results of Proprietary Cannabis Plant Extraction Technology with JV Partner Protex Pharma (TXTM)	07/20/07	NE
Republic of South Africa Medical Marijuana Dispensaries (RSAMMD) Signs Letter of Intent with USA-based Protext Pharma (TXTM) for Commercialization of Next Generation Live Cannabis and Hemp Extraction Technology	01/20/01	NE
Protext Pharma to Acquire Cannabis Blockchain Company Growprocess, Inc.	19/18/19	GL
Protext Pharma : Announces South Africa's Reclassification of Cannabis as a Schedule 4 Substance	20/17/20	MW
Protext Pharma : to Conduct Clinical Trial to Determine Therapeutic Dosage Levels for Treating Diabetes	13/17/13	MW
Protext Mobility : Completes Name Change to Protext Pharma and Provides Update on Medical Cannabis License	23/17/23	MW
Protext Mobility : Signs Agreement With Leading Research Center, CIDP, to Conduct Diabetes Human Clinical Trial	04/17/04	MW
Protext Mobility : Announces Acquisition of Cannabis Biosciences Inc.	27/17/27	MW
Protext Mobility : Discusses Potential Effectiveness of Phytofare Green Tea Extract in Treating Type II Diabetes	07/17/07	MW
Protext Mobility : Caps Off Week of Meetings in Mauritius With Visit to State House for Meeting With President Gurib-Fakim	03/17/03	MW
Protext Mobility : TXTM) Launches New Website and Social Media Channel	12/16/12	MW

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW